Familial Partial Lipodystrophy, Type 2
|
|
0.800 |
CausalMutation
|
CLINVAR |
|
|
|
Lethal tight skin contracture syndrome (disorder)
|
|
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder)
|
|
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
Progeria
|
|
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
Charcot-Marie-Tooth disease, Type 2B1
|
|
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
Mandibuloacral dysostosis
|
|
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
Malouf syndrome
|
|
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
Heart-hand syndrome, Slovenian type
|
|
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED (disorder)
|
|
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
Emery-Dreifuss Muscular Dystrophy 3
|
|
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
Cardiomyopathy, Familial Idiopathic
|
|
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
Lipodystrophy
|
|
0.050 |
GeneticVariation
|
BEFREE |
Lipodystrophy associated with LMNA mutation R482L causes loss of fat tissue.
|
29040816 |
2018 |
Pulmonary Fibrosis
|
|
0.010 |
GeneticVariation
|
BEFREE |
A clinical picture related to the LMNA Arg482Gln mutation may be more diversified than it was previously considered and include low BMI and pulmonary fibrosis.
|
19859838 |
2009 |
Familial partial lipodystrophy
|
|
0.100 |
GeneticVariation
|
BEFREE |
A genetic test revealed the presence of a heterozygous LMNA gene mutation: c.1445G>A, consistent with the "hot spot" for FPLD.
|
20625965 |
2010 |
Familial Partial Lipodystrophy, Type 2
|
|
0.800 |
GeneticVariation
|
UNIPROT |
A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy.
|
12629077 |
2003 |
Partial lipodystrophy
|
|
0.040 |
GeneticVariation
|
BEFREE |
Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes.
|
10810087 |
2000 |
Hyperinsulinism
|
|
0.030 |
GeneticVariation
|
BEFREE |
Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes.
|
10810087 |
2000 |
Familial partial lipodystrophy
|
|
0.100 |
GeneticVariation
|
BEFREE |
Both sisters were found to be heterozygous for the R482Q mutation in the lamin A/C gene (LMNA) gene, establishing the definitive diagnosis as Dunnigan-type familial partial lipodystrophy complicated by severe insulin resistance and secondary PCOS.
|
18728124 |
2008 |
Polycystic Ovary Syndrome
|
|
0.010 |
GeneticVariation
|
BEFREE |
Both sisters were found to be heterozygous for the R482Q mutation in the lamin A/C gene (LMNA) gene, establishing the definitive diagnosis as Dunnigan-type familial partial lipodystrophy complicated by severe insulin resistance and secondary PCOS.
|
18728124 |
2008 |
Familial partial lipodystrophy
|
|
0.100 |
GeneticVariation
|
BEFREE |
DNA sequencing of LMNA in five Canadian FPLD probands indicated that each had a novel missense mutation, R482Q, which co-segregated with the FPLD phenotype and was absent from 2000 normal alleles ( P = 1.1 x 10(-13)).
|
10587585 |
2000 |
Dyslipidemias
|
|
0.020 |
GeneticVariation
|
BEFREE |
FPLD was recently discovered to result from mutated LMNA (R482Q; OMIM #150330.0010), which is the gene encoding nuclear lamins A and C. Results from extended pedigrees indicate that dyslipidemia precedes the plasma glucose abnormalities in FPLD subjects with mutant LMNA, and that the hyperinsulinemia is present early in the course of the disease.
|
11122771 |
2000 |
Hyperinsulinism
|
|
0.030 |
GeneticVariation
|
BEFREE |
FPLD was recently discovered to result from mutated LMNA (R482Q; OMIM #150330.0010), which is the gene encoding nuclear lamins A and C. Results from extended pedigrees indicate that dyslipidemia precedes the plasma glucose abnormalities in FPLD subjects with mutant LMNA, and that the hyperinsulinemia is present early in the course of the disease.
|
11122771 |
2000 |
Hyperglycemia
|
|
0.700 |
CausalMutation
|
CLINVAR |
Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy.
|
10999845 |
2000 |
Monogenic diabetes
|
|
0.700 |
CausalMutation
|
CLINVAR |
Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy.
|
10999845 |
2000 |
Familial partial lipodystrophy
|
|
0.100 |
GeneticVariation
|
BEFREE |
Heterozygosity for LMNA R482Q mutation causes FPLD, which is associated with increased risk of hyperlipidemia and hypertension.
|
23313286 |
2013 |